Shares of Wuhan General Group Inc (OTCMKTS:WUHN) have been trading within a narrow range over the past few sessions.
Trading Data
On Wednesday, WUHN stock fell 2% to $0.25 with more than 14K shares traded, compared to its average volume of 43K shares. The stock moved within a range of $0.2400 – 0.2799 after opening trading at $0.2549.
Key Details
Bioceutical firm focusing on alternative plant-based cannabinoids and mental health therapeutic research, Wuhan General Group Inc (OTCMKTS:WUHN) on March 16, 2022, came out with the updates. M2Bio Sciences announced Chief Medical Officer and CEO Jeff Robinson would be attending Master Investor Show in London, UK on March 19, 2022.
The event would be hosting about 5000 attendees during the day and also feature investment categories including longevity, biotechnology, regenerative medicine, AI, blockchain, and agronomics. It will also feature the latest detailed report from personalities in the UK investment industry. Dr. Anna MoreraLeralta and Jeff Robinson will meet with institutional and retail investors and speakers Jim Mellon.
Jeff Robinson – CEO expressed excitement on him and Dr. Anna attending the fifth Master Investor Show. Robinson added that expanding knowledge base and network is critical. The CEO also extended an invitation to friends in London to join and meet up for coffee.
Master Investor annually hosts a flagship event, ‘The Master Investor Show’, bringing private investors with presentations, networking opportunities, and guidance from leading companies and experts within the investment and financial sectors. The event caters to a wide audience and is considered very important. Master Investor Show gives access to a spectrum of investment opportunities, from Funds and Trusts to Start-Ups in the early stages of fundraising.
Technical Data
WUHN stock is trading below the 20-Day and 50-Day Moving averages of $0.32 and $0.41 respectively. Moreover, the stock is trading below the 200-Day moving average of $0.49.
